Therefore, blocking mast cell, dendritic cell and macrophage-derived PGD2 production by inhibiting hPGDS could help to reduce eosinophil, basophil and Th2 cell numbers as well as inflammatory cytokine levels in atopic dermatitis lesions. This evidence concerns the gene PTGDS and atopic eczema.